Syntonix Pharmaceuticals' Series B Round

Syntonix Pharmaceuticals raised a round of funding on April 19, 2002.

Syntonix specializes in the discovery and development of therapeutic proteins for treatment of chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders.…

Articles about Syntonix Pharmaceuticals' Series B Round: